Condition
Advanced Chronic Liver Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Advanced Chronic Liver Disease clinical trials that are recruiting, at sites in 4 countries (most in Hong Kong (2), Canada (1), China (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Advanced Chronic Liver Disease clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Natural course of advanced chronic liver disease (cirrhosis) | — | Hong Kong | Recruiting | Jun 29, 2025 |
| Predicting liver disease complications and cancer development in patients | — | Münster, North Rhine-Westphalia | Recruiting | Jul 26, 2024 |
| Using carvedilol to prevent liver complications in patients with advanced chronic liver disease | Phase 4 | Hong Kong | Recruiting | Jun 10, 2024 |
| Liver and spleen stiffness testing to diagnose clinically significant portal hypertension | — | Montreal, Quebec | Recruiting | Dec 26, 2023 |
| Using 3D-MRE to assess liver disease and portal hypertension | — | Shenyang, Liaoning | Recruiting | Jul 26, 2022 |
All recruiting trials (5)
-
Natural course of advanced chronic liver disease (cirrhosis)
We will follow adults with advanced chronic liver disease for 10 years and use yearly transient elastography to see if and when liver complications or liver-related death occur.
-
Predicting liver disease complications and cancer development in patients
This study is testing if a new way of monitoring patients with advanced liver disease can help predict serious health issues and cancer better than standard care.
-
Using carvedilol to prevent liver complications in patients with advanced chronic liver disease
This study is testing if the medication carvedilol can help prevent serious liver problems in people with advanced chronic liver disease and high blood pressure in the liver.
-
Liver and spleen stiffness testing to diagnose clinically significant portal hypertension
This project tests whether liver and spleen stiffness measurements can predict portal-hypertension complications in adults with advanced chronic liver disease.
-
Using 3D-MRE to assess liver disease and portal hypertension
This study is testing if a new type of imaging called 3D-MRE can help doctors better understand and manage portal hypertension in patients with cirrhosis and advanced liver disease.
Related topics
Quick answers
How many Advanced Chronic Liver Disease clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Hong Kong (2 trials), Canada (1 trial), China (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.